Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Roberts, Lara N."" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł :
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis - Reply to Jacobs & Ryan comment.
Autorzy :
Speed V; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Roberts LN; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.
Arya R; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.
Patel JP; Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Mar; Vol. 19 (3), pp. 872-873.
Typ publikacji :
Letter; Comment
MeSH Terms :
Anticoagulants*
Rivaroxaban*/adverse effects
Body Weight ; Humans ; Thiophenes
Opinia redakcyjna
Tytuł :
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic.
Autorzy :
Patel R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland. Electronic address: .
Czuprynska J; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Roberts LN; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Vadher B; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Rea C; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Patel R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Gee E; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Saul G; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Coles E; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Brown A; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Byrne R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Speed V; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Patel JP; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Arya R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2021 Jan; Vol. 197, pp. 192-194. Date of Electronic Publication: 2020 Nov 07.
Typ publikacji :
Journal Article
MeSH Terms :
Pandemics*
SARS-CoV-2*
Anticoagulants/*therapeutic use
COVID-19/*complications
Drug Substitution/*methods
Pyridines/*therapeutic use
Rivaroxaban/*therapeutic use
Thiazoles/*therapeutic use
Thrombophilia/*drug therapy
Warfarin/*therapeutic use
Administration, Oral ; Anticoagulants/adverse effects ; COVID-19/blood ; COVID-19/epidemiology ; COVID-19/prevention & control ; Counseling ; Drug Monitoring ; Hospitals, University/organization & administration ; Hospitals, University/statistics & numerical data ; Humans ; Informed Consent ; London/epidemiology ; Patient Acceptance of Health Care ; Patient Education as Topic ; Pyridines/adverse effects ; Quarantine ; Rivaroxaban/adverse effects ; Telemedicine ; Tertiary Care Centers/organization & administration ; Tertiary Care Centers/statistics & numerical data ; Thiazoles/adverse effects ; Thrombophilia/etiology
Czasopismo naukowe
Tytuł :
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis.
Autorzy :
Speed V; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Green B; Model Answers R&D, Brisbane, QLD, Australia.
Roberts LN; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Woolcombe S; Department of Oral Surgery, King's College Hospital NHS Foundation Trust, London, UK.
Bartoli-Abdou J; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Barsam S; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Byrne R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Gee E; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Czuprynska J; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Brown A; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Duffy S; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Vadher B; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patel R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Scott V; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Gazes A; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patel RK; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Arya R; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patel JP; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Sep; Vol. 18 (9), pp. 2296-2307.
Typ publikacji :
Journal Article
MeSH Terms :
Obesity, Morbid*
Rivaroxaban*
Anticoagulants/adverse effects ; Blood Coagulation ; Body Mass Index ; Humans
Czasopismo naukowe
Tytuł :
Sub therapeutic rivaroxaban plasma concentrations following administration via Percutaneous Endoscopic Gastrostomy (PEG) feeding tubes - A note of caution.
Autorzy :
Byrne R; Department of Haematological Medicine, King's College Hospital, London, SE5 9RS, United Kingdom of Great Britain and Northern Ireland. Electronic address: .
Brown A; Department of Haematological Medicine, King's College Hospital, London, SE5 9RS, United Kingdom of Great Britain and Northern Ireland.
Patel JP; Department of Haematological Medicine, King's College Hospital, London, SE5 9RS, United Kingdom of Great Britain and Northern Ireland.
Czuprynska J; Department of Haematological Medicine, King's College Hospital, London, SE5 9RS, United Kingdom of Great Britain and Northern Ireland.
Roberts LN; Department of Haematological Medicine, King's College Hospital, London, SE5 9RS, United Kingdom of Great Britain and Northern Ireland.
Patel RK; Department of Haematological Medicine, King's College Hospital, London, SE5 9RS, United Kingdom of Great Britain and Northern Ireland.
Arya R; Department of Haematological Medicine, King's College Hospital, London, SE5 9RS, United Kingdom of Great Britain and Northern Ireland.
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2018 Aug; Vol. 168, pp. 102-103. Date of Electronic Publication: 2018 Jun 19.
Typ publikacji :
Letter
MeSH Terms :
Enteral Nutrition/*methods
Factor Xa Inhibitors/*therapeutic use
Gastrostomy/*methods
Rivaroxaban/*therapeutic use
Factor Xa Inhibitors/pharmacology ; Female ; Humans ; Male ; Rivaroxaban/pharmacology
Opinia redakcyjna
Tytuł :
Heavy menstrual bleeding on rivaroxaban.
Autorzy :
Ferreira M; King's Thrombosis Centre, King's College Hospital, London, UK. .; Department of Internal Medicine, Hospital Garcia de Orta, Almada, Portugal. .
Barsam S; King's Thrombosis Centre, King's College Hospital, London, UK.
Patel JP; King's Thrombosis Centre, King's College Hospital, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Czuprynska J; King's Thrombosis Centre, King's College Hospital, London, UK.
Roberts LN; King's Thrombosis Centre, King's College Hospital, London, UK.
Patel RK; King's Thrombosis Centre, King's College Hospital, London, UK.
Arya R; King's Thrombosis Centre, King's College Hospital, London, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2016 Apr; Vol. 173 (2), pp. 314-5. Date of Electronic Publication: 2015 Jul 27.
Typ publikacji :
Letter
MeSH Terms :
Factor Xa Inhibitors/*adverse effects
Menorrhagia/*chemically induced
Rivaroxaban/*adverse effects
Adolescent ; Adult ; Female ; Humans ; Middle Aged ; Pulmonary Embolism/drug therapy ; Venous Thrombosis/drug therapy ; Young Adult
Opinia redakcyjna
Tytuł :
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis.
Autorzy :
Speed, Victoria
Green, Bruce
Roberts, Lara N.
Woolcombe, Sarah
Bartoli‐Abdou, John
Barsam, Sarah
Byrne, Rosalind
Gee, Emma
Czuprynska, Julia
Brown, Alison
Duffy, Sinead
Vadher, Bipin
Patel, Rachna
Scott, Valerie
Gazes, Anna
Patel, Raj K.
Arya, Roopen
Patel, Jignesh P.
Pokaż więcej
Temat :
RIVAROXABAN
BODY mass index
BODY size
PHARMACOKINETICS
ANTICOAGULANTS
Źródło :
Journal of Thrombosis & Haemostasis; Sep2020, Vol. 18 Issue 9, p2296-2307, 12p, 3 Charts, 3 Graphs
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies